Trends in Chinese medicine use among prostate cancer patients under national health insurance in Taiwan: 1996-2008

Integrative Cancer Therapies

Volumn 10, Issue 4, 2011, Pages 317-327

  Lin, Yi Hsien ^a,b   Chen, Kuang Kuo ^a,c   Chiu, Jen Hwey ^a,b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

cancer; complementary medicine; health insurance; prostate; traditional Chinese medicine

Indexed keywords

CHINESE DRUG; HERBACEOUS AGENT;

ACUPUNCTURE; ADULT; AGED; ARTICLE; CHINESE HERB; CHINESE MEDICINE; DRUG USE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIPULATIVE MEDICINE; MONEY; PRIORITY JOURNAL; PROSTATE CANCER; TAIWAN; TREND STUDY;

ACUPUNCTURE THERAPY; AGED; AGED, 80 AND OVER; DRUGS, CHINESE HERBAL; HEALTH CARE COSTS; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; MUSCULOSKELETAL MANIPULATIONS; NATIONAL HEALTH PROGRAMS; OFFICE VISITS; PATIENT ACCEPTANCE OF HEALTH CARE; PROSTATIC NEOPLASMS; TAIWAN;

EID: 84855233474     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735410392576     Document Type: Article

References (36)

1. Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005 ; 16: 655-663 (Pubitemid 40613334)
2. Cassileth BR, Schraub S, Robinson E, Vickers A. Alternative medicine use worldwide: the International Union Against Cancer survey. Cancer. 2001 ; 91: 1390-1393 (Pubitemid 32267052)
3. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer. 1998 ; 83: 777-782 (Pubitemid 28387704)
4. Boon H, Westlake K, Stewart M, et al. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology. 2003 ; 62: 849-853 (Pubitemid 37421230)
5. Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology. 2005 ; 66: 1223-1228 (Pubitemid 41797295)
6. Diefenbach MA, Hamrick N, Uzzo R, et al. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer. J Urol. 2003 ; 170: 166-169 (Pubitemid 36734442)
7. Jones HA, Metz JM, Devine P, Hahn SM, Whittington R. Rates of unconventional medical therapy use in patients with prostate cancer: standard history versus directed questions. Urology. 2002 ; 59: 272-276 (Pubitemid 34134530)
8. Kao GD, Devine P. Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer. 2000 ; 88: 615-619 (Pubitemid 30056937)
9. Lippert MC, McClain R, Boyd JC, Theodorescu D. Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer. 1999 ; 86: 2642-2648 (Pubitemid 30004668)
10. Nam RK, Fleshner N, Rakovitch E, et al. Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J Urol. 1999 ; 161: 1521-1524 (Pubitemid 29420810)
11. Ponholzer A, Struhal G, Madersbacher S. Frequent use of complementary medicine by prostate cancer patients. Eur Urol. 2003 ; 43: 604-608 (Pubitemid 36648598)
12. Yoshimura K, Ueda N, Ichioka K, Matsui Y, Terai A, Arai Y. Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution. Support Care Cancer. 2005 ; 13: 685-690 (Pubitemid 41435559)
13. Quah SR. Traditional healing systems and the ethos of science. Soc Sci Med. 2003 ; 57: 1997-2012 (Pubitemid 37117348)
14. Wong TW, Wong SL, Donnan SP. Prevalence and determinants of the use of traditional Chinese medicine in Hong Kong. Asia Pac J Public Health. 1995 ; 8: 167-170
15. Hesketh T, Zhu WX. Health in China. Traditional Chinese medicine: one country, two systems. BMJ. 1997 ; 315: 115-117 (Pubitemid 27285449)
16. Yamashita H, Tsukayama H, Sugishita C. Popularity of complementary and alternative medicine in Japan: a telephone survey. Complement Ther Med. 2002 ; 10: 84-93
17. Chang LC, Huang N, Chou YJ, Lee CH, Kao FY, Huang YT. Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003. BMC Health Serv Res. 2008 ; 8: 170
18. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998 ; 280: 1569-1575 (Pubitemid 28520643)
19. Cassidy CM. Chinese medicine users in the United States. Part I. Utilization, satisfaction, medical plurality. J Altern Complement Med. 1998 ; 4: 17-27 (Pubitemid 128538822)
20. Wong-Kim E, Merighi JR. Complementary and alternative medicine for pain management in U.S.- and foreign-born Chinese women with breast cancer. J Health Care Poor Underserved. 2007 ; 18 (4 suppl). 118-129
21. Thomas KJ, Nicholl JP, Coleman P. Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med. 2001 ; 9: 2-11 (Pubitemid 32203876)
22. Chen FP, Chen TJ, Kung YY, et al. Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv Res. 2007 ; 7: 26
23. Lin YH, Chen KK, Chiu JH. Prevalence, patterns, and costs of Chinese medicine use among prostate cancer patients: a population-based study in Taiwan. Integr Cancer Ther. 2010 ; 9: 16-23
24. Rackley JD, Clark PE, Hall MC. Complementary and alternative medicine for advanced prostate cancer. Urol Clin North Am. 2006 ; 33: 237-246
25. Beebe-Dimmer JL, Wood DP, Gruber SB, et al. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study. Urology. 2004 ; 63: 282-287 (Pubitemid 38234419)
26. Yoshimura K, Ichioka K, Terada N, Terai A, Arai Y. Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan. Int J Clin Oncol. 2003 ; 8: 26-30 (Pubitemid 36305800)
27. Zimmerman RA, Thompson IM. Prevalence of complementary medicine in urologic practice. A review of recent studies with emphasis on use among prostate cancer patients. Urol Clin North Am. 2002 ; 29: 1-9 (Pubitemid 34733096)
28. Lee MM, Chang JS, Jacobs B, Wrensch MR. Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations. Am J Public Health. 2002 ; 92: 1606-1609
29. Jacobson JS, Chetty AP. Complementary and alternative medicine in prostate cancer. Curr Oncol Rep. 2001 ; 3: 448-452
30. Wilkinson S, Gomella LG, Smith JA, et al. Attitudes and use of complementary medicine in men with prostate cancer. J Urol. 2002 ; 168: 2505-2509 (Pubitemid 35402652)
31. Fair WR, Willet F, Whitore . Lecture: back to the future-the role of complementary medicine in urology. J Urol. 1999 ; 162: 411-420 (Pubitemid 29434352)
32. Hall JD, Bissonette EA, Boyd JC, Theodorescu D. Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study. BJU Int. 2003 ; 91: 603-607 (Pubitemid 36583727)
33. Wilkinson S, Chodak GW. Critical review of complementary therapies for prostate cancer. J Clin Oncol. 2003 ; 21: 2199-2210 (Pubitemid 46606370)
34. Pu CY, Lan VM, Lan CF, Lang HC. The determinants of traditional Chinese medicine and acupuncture utilization for cancer patients with simultaneous conventional treatment. Eur J Cancer Care (Engl). 2008 ; 17: 340-349
35. Liao HL, Ma TC, Chiu YL, Chen JT, Chang YS. Factors influencing the purchasing behavior of TCM outpatients in Taiwan. J Altern Complement Med. 2008 ; 14: 741-748
36. Shih SF, Lew-Ting CY, Chang HY, Kuo KN. Insurance covered and non-covered complementary and alternative medicine utilisation among adults in Taiwan. Soc Sci Med. 2008 ; 67: 1183-1189